InvestorsHub Logo
Followers 28
Posts 2769
Boards Moderated 0
Alias Born 03/24/2019

Re: None

Tuesday, 10/05/2021 1:02:13 PM

Tuesday, October 05, 2021 1:02:13 PM

Post# of 1209
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr. Matthew Johnson

https://psilocybinalpha.com/news/mydecine-to-supply-lead-drug-candidate-myco-001-for-multi-site-nida-grant-funded-smoking-cessation-study-lead-by-dr-matthew-johnson

"Dr. Johnson received a U01 grant from National Institute on Drug Abuse (NIDA) to fund this study, making it the first time in over 50 years that the U.S. government has funded a study of a psychedelic compound for therapeutics".